Prevention of Adhesions During Celioscopy for Endometriosis. Impact of the Use of Anti-adhesion Treatment on Clinical Signs and Fertility at One Year
NCT ID: NCT02612818
Last Updated: 2018-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
364 participants
OBSERVATIONAL
2015-11-24
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to describe, under real treatment conditions in patients suffering from endometriosis, the impact of the use of anti-adhesion treatment during celioscopy surgery on the development of clinical signs in the patients and their fertility at one year.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Surgical Management of Endometriosis on Fertility
NCT02481739
Post-operative Ovarian Adhesion Study in Women With Endometriosis
NCT01989260
Study of the Prevalence of Endometriosis and Adenomyosis
NCT06211569
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
NCT05683041
Incidence of Different Surgical Technics for Colorectal Deep Infiltrating EndoMetriosis on the Post-operative Fertility and Pregnancy Outcomes
NCT04681898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coelioscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients for whom spontaneous pregnancy is possible, whether or not they wish to become pregnant immediately.
* Patients accepting and able to update a questionnaire in French.
* Informed patients who agree to computerised processing of their medical data and their right of access and rectification.
Exclusion Criteria
* Patients presenting with an absolute or relative contra-indication for use of an anti-adhesion agent (severe allergic antecedents etc).
* Patients not wishing to become pregnant.
* Patients participating or having participated during the previous month in a gynaecological clinical trial.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nordic Pharma SAS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hélène HERMAN-DEMARS, MD
Role: STUDY_DIRECTOR
Nordic Pharma
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nordic Pharma
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ENDHY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.